Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0MJXDK
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
1959-SSS-DM3
|
|||||
| Synonyms |
1959 sss DM3
Click to Show/Hide
|
|||||
| Organization |
MediaPharma Srl, Universita Degli Studi Di L'Aquila
|
|||||
| Drug Status |
Clinical candidate
|
|||||
| Indication |
In total 2 Indication(s)
Melanoma [ICD11:2C30]
Clinical candidate
Neuroblastoma [ICD11:2A00]
Clinical candidate
|
|||||
| Drug-to-Antibody Ratio |
2
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Galectin-3-binding protein (LGALS3BP)
|
Antigen Info | ||||
| Payload Name |
Maytansinoid DM3
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
Undisclosed
|
|||||
If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.